DGX
DGX
US74834L1008
Quest Diagnostics Incorporated
Loading chart...

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Latest News

Related stocks

LH
LH • United States
Labcorp Holdings Inc.
312.15 USD
25.32B USD 1Y +13.2%
RVTY
RVTY • United States
Revvity, Inc.
154.18 USD
17.2B USD 1Y +65.8%
MEDP
MEDP • United States
Medpace Holdings, Inc.
612.05 USD
17.08B USD 1Y +13.5%
WAT
WAT • United States
Waters Corporation
433.77 USD
42.59B USD 1Y +31%
IQV
IQV • United States
IQVIA Holdings, Inc.
259.88 USD
42.78B USD 1Y +29.1%
A
A • United States
Agilent Technologies, Inc.
170.54 USD
48.08B USD 1Y +19.4%
GH
GH • United States
Guardant Health, Inc.
167.47 USD
22.47B USD 1Y +153.5%
ILMN
ILMN • United States
Illumina, Inc.
278.17 USD
42B USD 1Y +170.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
5Y Volatility
22.5% p.a.
Max Drawdown (5Y)
-30.3%
Sharpe Ratio (5Y)
0.34
Beta Factor
0.54
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
ende